GlassScriptPhysician profile
Joseph M Porres
NPI 1902835689
$1,947.56
in general payments reported to CMS, 2019-2025
19 companies · $366 in 2025
The $366 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.51 · 2020: $42.98 · 2021: $320 · 2022: $307 · 2023: $386 · 2024: $513 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,199 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,199.05 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $329.37 | 2020-2025 | |
| Dermavant Sciences, INC. | $304.40 | 2023-2024 | Vtama |
| Amgen INC. | $292.45 | 2020-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $208.17 | 2021-2024 | Tremfya, Remicade, Simponi |
| Botanix Sb INC | $169.68 | 2025 | Sofdra |
| Vector Surgical, LLC | $150.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $76.37 | 2022-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $66.50 | 2023-2025 | Zoryve |
| Organon LLC | $56.67 | 2025 | Vtama |
| Incyte Corporation | $54.12 | 2021-2022 | |
| Pfizer INC. | $46.41 | 2022-2023 | |
| Ucb, INC. | $39.41 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $36.42 | 2020-2024 | Jublia, Arazlo, Cabtreo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.95 | 2024 | Spevigo |
| Lilly USA, LLC | $29.38 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $15.25 | 2025 | |
| Kyowa Kirin, INC. | $14.01 | 2022 | |
| Galderma Laboratories, L.P. | $13.51 | 2019 | |
| Merck Sharp & Dohme LLC | $13.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Porres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.